Application 090723

Type
ANDA
Sponsor
MARKSANS PHARMA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DULOXETINE HYDROCHLORIDEDULOXETINE HYDROCHLORIDECAPSULE, DELAYED REL PELLETS;ORALEQ 20MG BASENoNo
002DULOXETINE HYDROCHLORIDEDULOXETINE HYDROCHLORIDECAPSULE, DELAYED REL PELLETS;ORALEQ 30MG BASENoNo
003DULOXETINE HYDROCHLORIDEDULOXETINE HYDROCHLORIDECAPSULE, DELAYED REL PELLETS;ORALEQ 60MG BASENoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
25000-608DuloxetineDuloxetine HydrochlorideMARKSANS PHARMA LIMITEDANDACurrent
25000-609DuloxetineDuloxetine HydrochlorideMARKSANS PHARMA LIMITEDANDACurrent
25000-610DuloxetineDuloxetine HydrochlorideMARKSANS PHARMA LIMITEDANDACurrent
45865-813DuloxetineDuloxetineMedsource PharmaceuticalsANDACurrent
45865-813DuloxetineDuloxetineMedsource PharmaceuticalsANDACurrent
45865-816DuloxetineDuloxetineMedsource PharmaceuticalsANDACurrent
45865-816DuloxetineDuloxetineMedsource PharmaceuticalsANDACurrent
68788-9266DuloxetineDuloxetinePreferred Pharmaceuticals, Inc.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
9287ORIG2013-12-13